Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Jan 05, 2026

SELL
$64.85 - $71.7 $23,216 - $25,668
-358 Closed
0 $0
Q1 2023

Jan 05, 2026

BUY
$63.15 - $71.6 $22,607 - $25,632
358 New
358 $24.9 Million

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $277B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Chesapeake Asset Management LLC Portfolio

Follow Chesapeake Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Chesapeake Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Chesapeake Asset Management LLC with notifications on news.